Checkpoint Capital »

Rhythm Pharmaceuticals shares owned by Checkpoint Capital

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $34M 730k 45.97

More positions owned by Checkpoint Capital

Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Spdr Biotech Etf Tr Unit Put Option (XBI)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Mirum Pharmaceuticals (MIRM)
Protagonist Therapeutics (PTGX)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Phathom Pharmaceuticals (PHAT)
Atyr Pharma Com New (LIFE)
Trevi Therapeutics (TRVI)
Gh Research Ordinary Shares (GHRS)
Allakos (ALLK)

View all positions for Checkpoint Capital

Top funds holding Rhythm Pharmaceuticals

PRIMECAP Management Company
Baker Bros. Advisors
RA Capital Management
Goldman Sachs Group
Vanguard Group
NEA Management Company
Frazier Life Sciences Management
Federated Investors
Perceptive Advisors
Commodore Capital
Checkpoint Capital
Henderson Group
Opaleye Management
T. Rowe Price Associates
Cormorant Asset Management

View all funds holding Rhythm Pharmaceuticals